Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 13.89%, which has investors questioning if this is ...

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has opened the reporting season for Israeli companies by ...

Teva reported fourth-quarter revenue of $4.2 billion, beating analyst estimates of $4.13 billion, according to Benzinga Pro.

Israeli generics giant Teva Pharmaceutical Industries today reported results for the year and the quarter ended December 31, ...

Teva’s first pair of true winter boots deliver on their promises. They’re not meant for arctic adventures but are great at ...

Reports Q4 revenue $4.2B, consensus $4.12B. Richard Francis, Teva‘s (TEVA) President and CEO, said: “2024 marked a transformative year for ...

NEW YORK - Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported fourth-quarter earnings that beat analyst estimates, but its shares fell sharply as the company's 2025 outlook came in below ...

Teva Pharmaceutical (NYSE:TEVA) lost ~5% in the premarket even after recording better-than-expected financials for Q4 2024 on Wednesday, as the generic drugmaker set its 2025 earnings outlook below ...

Although the revenue and EPS for Teva Pharmaceutical Industries (TEVA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics ...

In a report released today, Chris Schott from J.P. Morgan maintained a Hold rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Wealth host Brad Smith analyzes the latest earnings reports from Wall Street. VF Corp's (VFC) stock climbed following ...

Teva Pharmaceuticals USA Inc. is taking the Biden administration to court over its drug price negotiation program, days ...